LIFEVANTAGE CORP Inventory, Raw Materials, Gross
LIFEVANTAGE CORP (LFVN) had Inventory, Raw Materials, Gross of $4.21 million as of 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Notes › Inventory › Inventory, Net
us-gaap:InventoryRawMaterials · last filed 2026-08-27
- 2026-06-30: Inventory, Raw Materials, Gross $4.21M.
- 2025-06-30: Inventory, Raw Materials, Gross $2.93M.
- 2024-06-30: Inventory, Raw Materials, Gross $3.21M.
- 2023-06-30: Inventory, Raw Materials, Gross $3.92M.
| Period end | Inventory, Raw Materials, Gross | Inventory, Raw Materials, Gross as first filed |
|---|---|---|
| 2026-06-30 | $4.21M 10-K · filed 2026-08-27 | |
| 2025-06-30 | $2.93M 10-K · filed 2026-08-27 | |
| 2024-06-30 | $3.21M 10-K · filed 2025-09-04 | |
| 2023-06-30 | $3.92M 10-K · filed 2024-08-28 | |
| 2022-06-30 | $3.80M 10-K · filed 2023-08-28 | |
| 2021-06-30 | $3.92M 10-K · filed 2022-08-23 | |
| 2020-06-30 | $3.72M 10-K · filed 2021-08-19 | |
| 2019-06-30 | $3.85M 10-K · filed 2020-08-18 | |
| 2018-06-30 | $5.77M 10-K · filed 2019-08-14 | |
| 2017-06-30 | $8.76M 10-K · filed 2018-08-15 | |
| 2016-06-30 | $10.26M 10-K · filed 2017-09-07 | |
| 2015-06-30 | $3.46M 10-K · filed 2016-12-12 | |
| 2014-06-30 | $4.08M 10-K · filed 2015-09-01 | |
| 2013-06-30 | $5.25M 10-K · filed 2014-09-10 | |
| 2013-03-31 | $4.93M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $5.88M 10-Q · filed 2013-02-07 | |
| 2012-09-30 | $6.85M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $5.39M 10-K · filed 2013-09-12 | $5.39M 10-K · filed 2012-09-10 |
| 2011-06-30 | $1.39M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |